Dr. Munster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-885-3631Fax+1 415-353-7021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
- Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1996
- University of Bern Faculty of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 2008 - 2026
- FL State Medical License 2001 - 2010
- NY State Medical License 2000 - 2003
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsCombination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.Pamela Munster, Nicholas Iannotti, Daniel C Cho, John M Kirkwood, Liza C Villaruz
Cancer Research Communications. 2023-12-19 - 144 citationsPhase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid TumorsAdil Daud, Michelle T. Ashworth, Jonathan Strosberg, Jonathan W. Goldman, David S. Mendelson
Journal of Clinical Oncology. 2015-03-20 - 134 citationsA phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.Thomas Martin, Rachid Baz, Don M. Benson, Nikoletta Lendvai, Jeffrey L. Wolf
Blood. 2017-06-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: